Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1­10100-9 <br />283.1 (xxxvi) 17 [alpha] -methyl-4-hydroxynandrolone <br />283.2 (17 [alpha] -methyl-4-hydroxy- 17 [beta] -hydroxyestr-4-en-3 -one); <br />283.3 (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one); <br />283.4 (xxxviii) methyltienolone (17 [alpha]-methyl-17 [beta] -hydroxyestra-4,9-1 1-trien-3-one); <br />283.5 (xxxix) methyltestosterone (17 [alpha] -methyl- 17 [beta] -hydroxyandrost-4-en-3 -one); <br />283.6 (xl) mibolerone (7 [alpha], 17 [alpha] -dimethyl- 17 [beta] -hydroxyestr-4-en-3 -one); <br />283.7 (xli) 17 [alpha] -methyl- [delta] 1-dihydrotestosterone <br />283.8 (17 [beta] -hydroxy- 17 [alpha] -methyl-5 [alpha]-androst-l-en-3-one); <br />283.9 (xlii) nandrolone (17 [beta] -hydroxyestr-4-en-3 -one); <br />283.10 (xliii) 19-nor-4-androstenediol (3 [beta], 17 [beta]-dihydroxyestr-4-ene; <br />283.11 (xliv) 3 [alpha], 17 [beta] -dihydroxyestr-4-ene); 19-nor-5-androstenediol <br />283.12 (3 [beta], 17 [beta] -dihydroxyestr- 5 -ene; <br />283.13 (xlv) 3 [alpha], 17 [beta] -dihydroxyestr-5-ene); <br />283.14 (xlvi) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione); <br />283.15 (xlvii) 19-nor-5-androstenedione (estr-5-en-3,17-dione); <br />283.16 (xlviii) norbolethone (13 [beta], 17 [alpha] -diethyl-17 [beta] -hydroxygon-4-en-3 -one); <br />283.17 (xlix) norclostebol (4-chloro-17 [beta] -hydroxyestr-4-en-3 -one); <br />283.18 (1) norethandrolone (17 [alpha]-ethyl-17 [beta] -hydroxyestr-4-en-3 -one); <br />283.19 (li) normethandrolone (17 [alpha]-methyl-17 [beta] -hydroxyestr-4-en-3 -one); <br />283.20 (lii) oxandrolone (17 [alpha] -methyl- 17 [beta] -hydroxy-2-oxa-5 [alpha] -androstan-3 -one); <br />283.21 (liii) oxymesterone (17 [alpha] -methyl-4,17 [beta] -dihydroxyandrost-4-en-3 -one); <br />283.22 (liv) oxymetholone <br />283.23 (17 [alpha] -methyl-2-hydroxymethylene- 17 [beta]-hydroxy-5 [alpha]-androstan-3 -one); <br />283.24 (lv) prostanozol (17 beta-hydroxy-5 alpha- andro stano[3,2-C]pryazole; <br />283.25 (lvi) stanozolol <br />283.26 (17 [alpha] -methyl- 17 [beta] -hydroxy-5 [alpha] -androst-2-eno [3,2-c]-pyrazole); <br />283.27 (lvii) stenbolone (17 [beta]-hydroxy-2-methyl-5 [alpha]-androst-l-en-3-one); <br />283.28 (lviii) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-l7-oic acid lactone); <br />Article 8 Sec. 2. 283 <br />